Medicinova (MNOV) Total Non-Current Liabilities (2018 - 2025)

Medicinova (MNOV) has 8 years of Total Non-Current Liabilities data on file, last reported at $4.0 million in Q4 2025.

• On a quarterly basis, Total Non-Current Liabilities rose 26.52% year-over-year to $4.0 million in Q4 2025; TTM through Dec 2025 was $4.0 million, a 26.52% increase from a year earlier, with the FY2025 full-year figure at $4.0 million, up 26.52% from the prior year.
• Total Non-Current Liabilities for Q4 2025 stood at $4.0 million, up from $3.5 million in the prior quarter.
• Over the last five years, Total Non-Current Liabilities for MNOV reached as high as $4.7 million in Q3 2022 and fell as low as $2.3 million in Q1 2025.
• Historically, Total Non-Current Liabilities has averaged $3.4 million across 5 years, with a median of $3.2 million in 2022.
• Across the five-year window, Total Non-Current Liabilities sank 36.5% in 2023 and advanced 26.52% in 2025, its largest moves.
• Year by year, Total Non-Current Liabilities stood at $3.0 million in 2021, then climbed by 11.68% to $3.4 million in 2022, then rose by 2.7% to $3.5 million in 2023, then declined by 9.19% to $3.2 million in 2024, then rose by 26.52% to $4.0 million in 2025.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $4.0 million in Q4 2025, $3.5 million in Q3 2025, and $2.8 million in Q2 2025.